Skip to main content

Advertisement

Table 2 Early virologic (EVR) and sustained virologic response (SRV) according to the genotype and population characteristics.

From: Retreatment of hepatitis C patients with pegylated interferon combined with ribavirin in non-responders to interferon plus ribavirin. Is it different in real life?

Characteristics EVR Genotype 1 EVR Genotype 3 P value SVR Genotype 1 SVR Genotype 3 P value
Sex       
Men 23% (13/5) 65% (13/20) 0.9917 27% (17/62) 32% (10/3) 0.7612
Women 30% (7/23) 83% (5/6)   22% (6/27) 33% (3/9)  
Race Caucasian 28% (19/70) 60% (14/23) 0.7502 29% (14/47) 31% (12/38) 0.3662
Age       
< 40 years 33% (3/9) 100% (4/4) 0.4856 40% (4/10) 50% (3/6) 0.2694
> 40 years 28% (19/67) 59% (13/22)   24% (18/75) 29% (10/34)  
Alcohol abuse       
Yes 22% (5/22) 20% (1/5) 0.1798 29% (8/27) 12% (1/8) 1.1
No 27% (15/55) 755 (15/20)   36% (15/41) 36% (12/33)  
Exposure n (%)       
IVDU 37% (6/16) 55% (5/9)   25% (4/16) 30% (4/13)  
Parenteral 29% (8/27) 50% (3/6) 0.7038 25% (8/32) 36% (4/11) 1.073
Parenteral/IVDU 0% (0/3) 0% (0/1) 0.6794 0% (0/3) 25% (1/4) 1.053
Unknown 18% (6/32) 88% (8/9)   25% (4/16) 38% (5/13)  
  1. p value < 0.005 = significant